This study is testing whether a combination of three drugs can help control advanced colorectal cancer that has stopped responding to standard treatments. It is for patients with a specific type of cancer and a certain gut bacteria. The main goal is to see if this new approach ca…
Phase: PHASE2 • Sponsor: Jing-yuan Fang, MD, Ph. D • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC